IL6 and COVID-19: In summary, our in vitro study demonstrates that that serum from COVID-19 patients with delirium can detrimentally affect human hippocampal neurogenesis, and that this effect is mediated by IL6-induced production of the downstream inflammatory cytokines IL12 and IL13, which are ultimately responsible for the negative cellular outcomes.